Involvement of caspase-9 in autophagy-mediated cell survival pathway

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1813, Issue 1, 2011, Pages 80-90

  Jeong, Hyo Soon ^a   Choi, Hye Yeon ^a   Lee, Eung Ryoung ^a   Kim, Jung Hyun ^a   Jeon, Kilsoo ^a   Lee, Hyun Joo ^a   Cho, Ssang Goo ^a  

^a Konkuk University   (South Korea)

Author keywords

Apoptosis; Autophagy; Caspase; MCF 7; NSAIDs

Indexed keywords

CASPASE 8; CASPASE 9; CATHEPSIN; DOXORUBICIN; ETOPOSIDE; FR 122047; NONSTEROID ANTIINFLAMMATORY AGENT; SMALL INTERFERING RNA; SULFORAPHANE; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; AUTOPHAGY; BREAST CANCER; CELL DEATH; CELL PROTECTION; CELL STRAIN MCF 7; CELL SURVIVAL; ELECTRON MICROSCOPY; ENZYME ACTIVATION; ENZYME INHIBITION; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN CELL CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANTIBIOTICS, ANTINEOPLASTIC; ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; AUTOPHAGY; BLOTTING, WESTERN; BREAST NEOPLASMS; CASPASE 9; CELL PROLIFERATION; CELL SURVIVAL; CYTOPLASM; DOXORUBICIN; ENZYME ACTIVATION; ETOPOSIDE; FEMALE; FLOW CYTOMETRY; HUMANS; MITOCHONDRIA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; THIOCYANATES; TUMOR CELLS, CULTURED;

EID: 78650746461     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2010.09.016     Document Type: Article

References (44)

1. Baek S.J., Eling T.E. Changes in gene expression contributes to cancer prevention by COX inhibitors. Prog. Lipid Res. 2006, 45:1-16.
2. Lupulescu A. Prostaglandins, their inhibitors and cancer. Prostaglandins Leukot. Essent. Fatty Acids 1996, 54:83-94.
3. Kundu N., Fulton A.M. Selective cyclooxygenase (COX)-1 or COX-2 inhibitors control metastatic disease in a murine model of breast cancer. Cancer Res. 2002, 62:2343-2346.
4. Mazhar D., Ang R., Waxman J. COX inhibitors and breast cancer. Br. J. Cancer 2006, 94:346-350.
5. Harris R.E., Namboodiri K., Stellman S.D., Wynder E.L. Breast cancer and NSAID use: heterogeneity of effect in a case-control study. Prev. Med. 1995, 24:119-120.
6. Harris R.E., Chlebowski R.T., Jackson R.D., Frid D.J., Ascenseo J.L., Anderson G., Loar A., Rodabough R.J., White E., McTiernan A. Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative. Cancer Res. 2003, 63:6096-6101.
7. Schreinemachers D.M., Everson R.B. Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology 1994, 5:138-146.
8. Baron J.A., Sandler R.S. Nonsteroidal anti-inflammatory drugs and cancer prevention. Annu. Rev. Med. 2000, 51:511-523.
9. Wang W.H., Huang J.Q., Zheng G.F., Lam S.K., Karlberg J., Wong B.C. Non-steroidal anti-inflammatory drug use and the risk of gastric cancer: a systematic review and meta-analysis. J. Natl Cancer Inst. 2003, 95:1784-1791.
10. Cheng I., Liu X., Plummer S.J., Krumroy L.M., Casey G., Witte J.S. COX2 genetic variation, NSAIDs, and advanced prostate cancer risk. Br. J. Cancer 2007, 97:557-561.
11. Ochi T., Motoyama Y., Goto T. The analgesic effect profile of FR122047, a selective cyclooxygenase-1 inhibitor, in chemical nociceptive models. Eur. J. Pharmacol. 2000, 391:49-54.
12. Ochi T., Goto T. Differential effect of FR122047, a selective cyclo-oxygenase-1 inhibitor, in rat chronic models of arthritis. Br. J. Pharmacol. 2002, 135:782-788.
13. Abraham M.C., Shaham S. Death without caspases, caspases without death. Trends Cell Biol. 2004, 14:184-193.
14. Uchiyama R., Kawamura I., Fujimura T., Kawanishi M., Tsuchiya K., Tominaga T., Kaku T., Fukasawa Y., Sakai S., Nomura T., Mitsuyama M. Involvement of caspase-9 in the inhibition of necrosis of RAW 264 cells infected with Mycobacterium tuberculosis. Infect. Immun. 2007, 75:2894-2902.
15. Shah N., Asch R.J., Lysholm A.S., Lebien T.W. Enhancement of stress-induced apoptosis in B-lineage cells by caspase-9 inhibitor. Blood 2004, 104:2873-2878.
16. Thorburn A. Apoptosis and autophagy: regulatory connections between two supposedly different processes. Apoptosis 2008, 13:1-9.
17. Yorimitsu T., Klionsky D.J. Autophagy: molecular machinery for self-eating. Cell Death Differ. 2005, 12(Suppl 2):1542-1552.
18. Codogno P., Meijer A.J. Autophagy and signaling: their role in cell survival and cell death. Cell Death Differ. 2005, 12(Suppl 2):1509-1518.
19. Amaravadi R.K., Yu D., Lum J.J., Bui T., Christophorou M.A., Evan G.I., Thomas-Tikhonenko A., Thompson C.B. Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J. Clin. Invest. 2007, 117:326-336.
20. Abedin M.J., Wang D., McDonnell M.A., Lehmann U., Kelekar A. Autophagy delays apoptotic death in breast cancer cells following DNA damage. Cell Death Differ. 2007, 14:500-510.
21. Janicke R.U., Sprengart M.L., Wati M.R., Porter A.G. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J. Biol. Chem. 1998, 273:9357-9360.
22. Ferguson H.A., Marietta P.M., Van Den Berg C.L. UV-induced apoptosis is mediated independent of caspase-9 in MCF-7 cells: a model for cytochrome c resistance. J. Biol. Chem. 2003, 278:45793-45800.
23. Herman-Antosiewicz A., Johnson D.E., Singh S.V. Sulforaphane causes autophagy to inhibit release of cytochrome c and apoptosis in human prostate cancer cells. Cancer Res. 2006, 66:5828-5835.
24. Kabeya Y., Mizushima N., Ueno T., Yamamoto A., Kirisako T., Noda T., Kominami E., Ohsumi Y., Yoshimori T. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 2000, 19:5720-5728.
25. Yanagisawa H., Miyashita T., Nakano Y., Yamamoto D. HSpin1, a transmembrane protein interacting with Bcl-2/Bcl-xL, induces a caspase-independent autophagic cell death. Cell Death Differ. 2003, 10:798-807.
26. Akdemir F., Farkas R., Chen P., Juhasz G., Medved'ova L., Sass M., Wang L., Wang X., Chittaranjan S., Gorski S.M., Rodriguez A., Abrams J.M. Autophagy occurs upstream or parallel to the apoptosome during histolytic cell death. Development 2006, 133:1457-1465.
27. Cao C., Subhawong T., Albert J.M., Kim K.W., Geng L., Sekhar K.R., Gi Y.J., Lu B. Inhibition of mammalian target of rapamycin or apoptotic pathway induces autophagy and radiosensitizes PTEN null prostate cancer cells. Cancer Res. 2006, 66:10040-10047.
28. Ravikumar B., Berger Z., Vacher C., O'Kane C.J., Rubinsztein D.C. Rapamycin pre-treatment protects against apoptosis. Hum. Mol. Genet. 2006, 15:1209-1216.
29. Ivy G.O., Schottler F., Wenzel J., Baudry M., Lynch G. Inhibitors of lysosomal enzymes: accumulation of lipofuscin-like dense bodies in the brain. Science 1984, 226:985-987.
30. Bursch W. The autophagosomal-lysosomal compartment in programmed cell death. Cell Death Differ. 2001, 8:569-581.
31. Sheng H., Shao J., Morrow J.D., Beauchamp R.D., DuBois R.N. Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res. 1998, 58:362-366.
32. Lanza-Jacoby S., Dicker A.P., Miller S., Rosato F.E., Flynn J.T., Lavorgna S.N., Burd R. Cyclooxygenase (COX)-2-dependent effects of the inhibitor SC236 when combined with ionizing radiation in mammary tumor cells derived from HER-2/neu mice. Mol. Cancer Ther. 2004, 3:417-424.
33. Hanif R., Pittas A., Feng Y., Koutsos M.I., Qiao L., Staiano-Coico L., Shiff S.I., Rigas B. Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. Biochem. Pharmacol. 1996, 52:237-245.
34. Kim S.H., Song S.H., Kim S.G., Chun K.S., Lim S.Y., Na H.K., Kim J.W., Surh Y.J., Bang Y.J., Song Y.S. Celecoxib induces apoptosis in cervical cancer cells independent of cyclooxygenase using NF-kappaB as a possible target. J. Cancer Res. Clin. Oncol. 2004, 130:551-560.
35. Tegeder I., Pfeilschifter J., Geisslinger G. Cyclooxygenase-independent actions of cyclooxygenase inhibitors. FASEB J. 2001, 15:2057-2072.
36. Jia L., Dourmashkin R.R., Allen P.D., Gray A.B., Newland A.C., Kelsey S.M. Inhibition of autophagy abrogates tumour necrosis factor alpha induced apoptosis in human T-lymphoblastic leukaemic cells. Br. J. Haematol. 1997, 98:673-685.
37. Gyrd-Hansen M., Farkas T., Fehrenbacher N., Bastholm L., Hoyer-Hansen M., Elling F., Wallach D., Flavell R., Kroemer G., Nylandsted J., Jaattela M. Apoptosome-independent activation of the lysosomal cell death pathway by caspase-9. Mol. Cell. Biol. 2006, 26:7880-7891.
38. Sato K., Aytac U., Yamochi T., Yamochi T., Ohnuma K., McKee K.S., Morimoto C., Dang N.H. CD26/dipeptidyl peptidase IV enhances expression of topoisomerase II alpha and sensitivity to apoptosis induced by topoisomerase II inhibitors. Br. J. Cancer 2003, 89:1366-1374.
39. Stupack D.G., Teitz T., Potter M.D., Mikolon D., Houghton P.J., Kidd V.J., Lahti J.M., Cheresh D.A. Potentiation of neuroblastoma metastasis by loss of caspase-8. Nature 2006, 439:95-99.
40. Fernando P., Brunette S., Megeney L.A. Neural stem cell differentiation is dependent upon endogenous caspase 3 activity. FASEB J. 2005, 19:1671-1673.
41. Wu Y.T., Tan H.L., Huang Q., Kim Y.S., Pan N., Ong W.Y., Liu Z.G., Ong C.N., Shen H.M. Autophagy plays a protective role during zVAD-induced necrotic cell death. Autophagy 2008, 4:457-466.
42. Lee E.R., Kang Y.J., Kim J.H., Lee H.T., Cho S.G. Modulation of apoptosis in HaCaT keratinocytes via differential regulation of ERK signaling pathway by flavonoids. J. Biol. Chem. 2005, 280:31498-31507.
43. Kim B.W., Lee E.R., Min H.M., Jeong H.S., Ahn J.Y., Kim J.H., Choi H.Y., Choi H., Kim E.Y., Park S.P., Cho S.G. Sustained ERK activation is involved in the kaempferol-induced apoptosis of breast cancer cells and is more evident under 3-D culture condition. Cancer Biol. Ther. 2008, 7:1080-1089.
44. Kern M.A., Haugg A.M., Koch A.F., Schilling T., Breuhahn K., Walczak H., Fleischer B., Trautwein C., Michalski C., Schulze-Bergkamen H., Friess H., Stremmel W., Krammer P.H., Schirmacher P., Muller M. Cyclooxygenase-2 inhibition induces apoptosis signaling via death receptors and mitochondria in hepatocellular carcinoma. Cancer Res. 2006, 66:7059-7066.